Skip to content

ANIK

Anika Therapeutics, Inc.

NASDAQ · Healthcare · Medical - Devices · US

$20.81
−0.90%
Ask drillr
1
Insider buys (3m)
0
Insider sells (3m)
$20.7K
Net value (3m)
+45.4%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 5, 2026Fischetti Gary P · directorPurchase1,000$21
Jun 23, 2026Fischetti Gary P · directorA-Award10,402$0.00
Jun 23, 2026CONLEY SHERYL L · directorA-Award10,402$0.00
Jun 23, 2026HENNEMAN JOHN B III · directorA-Award10,402$0.00
Jun 23, 2026Richard Stephen · directorA-Award10,402$0.00
Jun 23, 2026Capper Joseph H · directorA-Award10,402$0.00
Jun 5, 2026Griffin Stephen D. · director, officer: President and CEOF-InKind3,769$14
Jun 5, 2026Griffin Stephen D. · director, officer: President and CEOM-Exempt12,840$0.00
May 4, 2026HENNEMAN JOHN B III · directorPurchase5,000$15
Apr 30, 2026Griffin Stephen D. · director, officer: President and CEOPurchase12,200$12
Mar 23, 2026McLeod Ian · officer: SVP, CAO & TreasurerA-Award11,194$0.00
Mar 23, 2026McLeod Ian · officer: SVP, CAO & TreasurerA-Award17,663$16
Mar 23, 2026McLeod Ian · officer: SVP, CAO & TreasurerA-Award13,097$0.00
Mar 17, 2026Blanchard Cheryl R · directorA-Award24,520$0.00
Mar 17, 2026Blanchard Cheryl R · directorF-InKind12,104$14
Mar 17, 2026Griffin Stephen D. · director, officer: President and CEOF-InKind5,944$14
Mar 17, 2026Griffin Stephen D. · director, officer: President and CEOM-Exempt12,824$0.00
Mar 17, 2026McLeod Ian · officer: SVP, CAO & TreasurerF-InKind781$14
Mar 17, 2026Blanchard Cheryl R · directorM-Exempt25,131$0.00
Mar 17, 2026Colleran David · officer: EVP, General Counsel, Corp SecM-Exempt6,449$0.00
Mar 17, 2026McLeod Ian · officer: SVP, CAO & TreasurerM-Exempt3,774$0.00
Mar 17, 2026McLeod Ian · officer: SVP, CAO & TreasurerF-InKind1,449$14
Mar 17, 2026Griffin Stephen D. · director, officer: President and CEOA-Award6,412$0.00
Mar 17, 2026Blanchard Cheryl R · directorM-Exempt24,519$0.00
Mar 17, 2026Colleran David · officer: EVP, General Counsel, Corp SecF-InKind4,168$14
Mar 17, 2026McLeod Ian · officer: SVP, CAO & TreasurerM-Exempt2,658$0.00
Mar 17, 2026Blanchard Cheryl R · directorF-InKind14,728$14
Mar 17, 2026Colleran David · officer: EVP, General Counsel, Corp SecM-Exempt9,388$0.00
Mar 17, 2026Colleran David · officer: EVP, General Counsel, Corp SecF-InKind1,893$14
Mar 17, 2026Colleran David · officer: EVP, General Counsel, Corp SecA-Award4,694$0.00
Institutional positioning

13F filings over the trailing two quarters

New 46Increased 97Reduced 84Sold out 12
FilerActionSharesFiled
BLACKROCK, INC.Reduced1,594,893May 13, 2026
BlackRock, Inc.Reduced1,449,671Aug 7, 2026
Caligan Partners LPUnchanged1,435,130Aug 14, 2026
CALIGAN PARTNERS LPUnchanged1,435,130May 15, 2026
MORGAN STANLEYReduced872,066May 15, 2026
MORGAN STANLEYReduced614,320Aug 13, 2026
ACADIAN ASSET MANAGEMENT LLCUnchanged606,544Aug 13, 2026
ACADIAN ASSET MANAGEMENT LLCUnchanged606,544May 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position605,777May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCReduced572,113Aug 13, 2026
AQR CAPITAL MANAGEMENT LLCIncreased559,846Aug 14, 2026
BOOTHBAY FUND MANAGEMENT, LLCIncreased529,640Aug 14, 2026
BOOTHBAY FUND MANAGEMENT, LLCReduced529,503May 15, 2026
RENAISSANCE TECHNOLOGIES LLCReduced502,217May 14, 2026
RENAISSANCE TECHNOLOGIES LLCReduced481,417Aug 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 5, 2026